The website of Pathology In Practice Magazine

CORONAVIRUS NEWS

Introducing a new disruptive T-cell test

As the SARS-CoV-2 pandemic continues to cause concerns, with new variants spreading worldwide, it is now widely recognised that there must be a move beyond a ‘test & trace’ only approach.

Measuring neutralising antibodies against SARS-CoV-2 virus

Bio-Rad Laboratories has launched Bio-Plex Pro Human SARS-CoV-2 Variant neutralisation antibody assays, which allow scientists to measure neutralising antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus.

Support for Public Health Wales in the fight against SARS-CoV-2

Public Health Wales uses Seegene’s Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay and Allplex SARS-CoV-2 Variant Assay to help with the nation’s fight against SARS-CoV-2.

A statement on the new Omicron variant of SARS-CoV-2 (B.1.1.529)

Geoff Twist, Managing Director, Roche Diagnostics UK and Ireland has issued a statement on the new Omicron variant.

Moves to safeguard consumer interests around PCR testing welcomed

Randox has responded to a recent announcement on PCR testing by the Consumer and Markets Authority (CMA).

High-multiplex PCR assay capable of detecting Omicron variant

Seegene, South Korea's leading molecular diagnostics company, has confirmed that its Allplex SARS-CoV-2 Master Assay is capable of detecting Omicron's unique pattern of mutations.

Glasgow Centre for Virus Research wins Queen’s Anniversary Prize

The MRC-University of Glasgow Centre for Virus Research has been recognised with a Queen’s Anniversary Prize.

Discovering ‘Virus Velcro’: COVID-capturing face mask filter

Scientists have developed a new and affordable formulation to increase the effectiveness of face covering filters at trapping coronavirus particles, retaining up to 99.6% of the virus.

Immunoassay panels to study SARS-CoV-2 antibody response

Bio-Rad Laboratories has announced the launch of the Bio-Plex Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens.

Why some individuals have stronger natural defences against SARS-COV-2

A new study has revealed key insights into the natural human antiviral defences against SARS-CoV-2, the virus that causes COVID-19.

State-of-the-art PCR testing laboratory at Liverpool airport

Salutaris People, a British healthcare and testing company, has unveiled a brand new SARS-CoV-2 testing laboratory at Liverpool John Lennon Airport.

Screening for SARS-CoV-2 faster with AI than lateral-flow tests

Researchers at the University of Oxford are seeking NHSX funding for an artificial intelligence (AI) SARS-CoV-2 screening test.

App to help demystify the effect of SARS-CoV-2 mutations

The SARS-CoV-2 pandemic has focused everyone’s attention on the hidden world of viruses. The emergence of new variants, such as Beta and Delta, affects everyone: some variants spread more quickly and some are less affected by vaccines. But why?

Setting the pace for monitoring SARS-CoV-2 mutations and variants

Scientists at Children’s Hospital Los Angeles have been paying close attention to the behaviour of SARS-CoV-2 since the beginning of the pandemic, and have read the genetic sequence of the virus from every positive sample to identify mutations.

Vaccine-induce immune thrombocytopenia and thrombosis: an ELISA

Stago has developed Asserachrom HPIA-IgG, a highly sensitive and specific ELISA for detecting anti-heparin-PF4 IgG antibodies, which has recently found application in the diagnosis of VITT.

Research project to investigate support for Long Covid patients

The University of Lincoln in the UK, alongside five other British universities, will work on potentially ground-breaking research commissioned by the National Institute for Health Research (NIHR) to understand and tackle Long Covid.

Bottleneck in SARS-CoV-2 vaccine production eliminated

Biotage is one of the few companies offering a complete solution and ready-to-go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production.

Catching COVID-19: keeping pace through artificial intelligence

South Korea’s response to the pandemic has been praised, achieving success through rigorous preparation and rapid response, attributed to decisive government action, aggressive track-and-trace policies and almost immediate access to PCR tests.

Real-time PCR kit differentiates Alpha, Beta and Gamma variants

BD and CerTest Biotec have announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.

Capturing viral particles for SARS-CoV-2 detection

Owlstone Medical has announced the publication of a study in Nature Scientific Reports that investigates the performance of filters in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS).

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025